Phase I dose escalation of the oral histone deacetylase inhibitor (HDACi) resminostat in combination with FOLFIRI in colorectal cancer (CRC) patients: The SHORE trial
Schulze-Bergkamen, Henning, Jaeger, Dirk, Kopp, Hans-Georg, Mayer, Frank, Bitzer, Michael, Mais, Anna, Resemann, Karin, Hauns, Bernhard, Asche, Julia, Henning, Stefan W., Hentsch, Bernd
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article